We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $111M
1-Year Est. Return 74.4%
This Fund
S&P 500
This Quarter Est. Return
-14.56%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$688M
AUM Growth
-$52M
Cap. Flow
-$179M
Cap. Flow %
-26.07%
Top 10 Hldgs %
65.57%
Holding
231
New
46
Increased
68
Reduced
48
Closed
42

Top Buys

Rank Stock Value
1
AIOS
AIOS Tech
AIOS
+$28.5M
2
AGMH icon
AGM Group Holdings
AGMH
+$13.2M
3
OG
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
+$7.66M
4
ESPR
Esperion Therapeutics
ESPR
+$7.53M
5
CNTX icon
Context Therapeutics
CNTX
+$6.14M

Top Sells

Rank Stock Value
1
ZNB
Zeta Network Group
ZNB
+$3.39M
2
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$3.33M
3
TCDA
Tricida, Inc. Common Stock
TCDA
+$3.06M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$2.84M
5
FLUX icon
Flux Power
FLUX
+$2.59M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.53%
2 Healthcare 8.91%
3 Financials 5.9%
4 Technology 5.82%
5 Consumer Discretionary 1.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUPH icon
76
CALL
Aurinia Pharmaceuticals
AUPH
$2.14B
$1.07M 0.16%
469
– –
TCDA
77
PUT
DELISTED
Tricida, Inc. Common Stock
TCDA
$1.07M 0.16%
+1,116
New +$7.2K
POL
78
PUT
DELISTED
Polished.com Inc.
POL
$1.05M 0.15%
88
-48
-35% -$6.46K
GYRE icon
79
Gyre Therapeutics
GYRE
$714M
$1.04M 0.15%
151,778
+137,679
+977% +$2.35M
ASLN
80
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$1.01M 0.15%
22,496
+5,286
+31% +$317K
FLUX icon
81
Flux Power
FLUX
$11.9M
$976K 0.14%
227,599
-487,612
-68% -$2.59M
INFI
82
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$972K 0.14%
4,321
+468
+12% +$1.18K
KRBP
83
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$956K 0.14%
20,833
+4,896
+31% +$334K
STAB
84
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$885K 0.13%
384,597
+18,137
+5% +$53.5K
MTVA
85
MetaVia Inc
MTVA
$10.7M
$862K 0.13%
+268
New +$1.21M
NCTY
86
PUT
The9 Ltd
NCTY
$63.8M
$860K 0.13%
128
-98
-43% -$9.95K
ATNM icon
87
CALL
Actinium Pharmaceuticals
ATNM
$44M
$840K 0.12%
1,398
+1,193
+582% +$8.95K
NCTY
88
The9 Ltd
NCTY
$63.8M
$840K 0.12%
12,533
+7,264
+138% +$738K
VANI icon
89
Vivani Medical
VANI
$115M
$802K 0.12%
163,991
+66,667
+69% +$487K
PDSB icon
90
CALL
PDS Biotechnology
PDSB
$22.3M
$756K 0.11%
933
+2
+0.2% +$22
POL
91
DELISTED
Polished.com Inc.
POL
$738K 0.11%
6,150
+115
+2% +$15.5K
AUTL
92
Autolus Therapeutics
AUTL
$516M
$712K 0.1%
137,239
-162,761
-54% -$977K
ADTX
93
DELISTED
ADITXT INC
ADTX
– –
0
– –
ANY icon
94
Sphere 3D
ANY
$25.5M
$655K 0.1%
+2,997
New +$1.16M
VTGN icon
95
PUT
VistaGen Therapeutics
VTGN
$10.8M
$651K 0.09%
111
+103
+1,288% +$6.7K
KUST
96
Kustom Entertainment Inc
KUST
$4.22M
$645K 0.09%
1
-2
-67% -$1.4M
IKT icon
97
Inhibikase Therapeutics
IKT
$327M
$625K 0.09%
70,836
– –
SLAI
98
PUT
DELISTED
SOLAI Ltd ADS
SLAI
$615K 0.09%
14
-27
-66% -$14.8K
LEXXW
99
DELISTED
Lexaria Bioscience Warrant
LEXXW
$613K 0.09%
408,814
+75,843
+23% +$148K
WIMI
100
PUT
WiMi Hologram Cloud
WIMI
$18.9M
$603K 0.09%
198
-143
-42% -$5.78K
2 3
4
5 6

Similar funds

IWA
Independent Wealth Advisors Cary, North Carolina $111M AUM
BFA
Ballast Financial Advisors West Chester, Pennsylvania $110M AUM
WPWM
Western Pacific Wealth Management Lake Forest, Illinois $111M AUM 26.64% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
ZS
Zenith Solutions Philadelphia, Pennsylvania $110M AUM
KC
Karras Company Roy, Utah $110M AUM
FI
FinArc Investments Norwood, Massachusetts $110M AUM
CIM
Catalyst Investment Management Windham, New Hampshire $110M AUM

Sabby Management's Q4 2021 Portfolio in Review

As of Q4 2021, Sabby Management held 231 positions worth $688M, down 7% from $740M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Sabby Management withdrew a net $179M in Q4 2021, closing 42 positions and reducing 48 holdings. Its most notable exit was Tricida, Inc. Common Stock, an estimated $3.06M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, down from 77% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Sabby Management opened a new position in AIOS Tech worth $10.4M.

  • Sabby Management's largest Q4 2021 buy was AIOS Tech: 16,134 shares worth $10.4M.
  • Sabby Management added most to Acutus Medical Inc in Q4 2021, an estimated $3.52M increase.
  • Sabby Management's biggest Q4 2021 reduction was iPath Series B S&P 500 VIX Short-Term Futures ETN, cutting an estimated $3.33M.
  • Sabby Management fully exited Tricida, Inc. Common Stock in Q4 2021, selling an estimated $3.06M.
  • Sabby Management's ten largest holdings make up 66% of its $688M portfolio in Q4 2021.
  • Sabby Management opened 46 new positions and closed 42 in Q4 2021.
  • Sabby Management's portfolio value fell 7% quarter-over-quarter to $688M.

Based on Sabby Management's 13F filing for Q4 2021, filed 14 Feb 2022.